1. Cell Cycle/DNA Damage
  2. Nucleoside Antimetabolite/Analog
  3. 6-Mercaptopurine hydrate

6-Mercaptopurine hydrate  (Synonyms: 6-巯基嘌呤 一水合物; Mercaptopurine hydrate; 6-MP hydrate)

目录号: HY-13677A 纯度: 99.74%
COA 产品使用指南

6-Mercaptopurine hydrate (Mercaptopurine hydrate; 6-MP hydrate) 是一种嘌呤类似物,是内源性嘌呤的拮抗剂且已被广泛用作抗白血病活性分子和免疫抑制活性分子。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

6-Mercaptopurine hydrate Chemical Structure

6-Mercaptopurine hydrate Chemical Structure

CAS No. : 6112-76-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥258
In-stock
5 mg ¥235
In-stock
10 mg ¥330
In-stock
50 mg ¥450
In-stock
100 mg ¥650
In-stock
500 mg ¥990
In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of 6-Mercaptopurine hydrate:

    6-Mercaptopurine hydrate purchased from MCE. Usage Cited in: Nat Commun. 2022 Nov 17;13(1):7031.  [Abstract]

    6-Mercaptopurine (6-MP; 300 µM; pretreatment for 2 h) significantly inhibits EcSTH-induced phosphorylation of AMPK and ACC1 in HeLaTet-on EcSTH and MDA-MB-231Tet-on EcSTH cells.
    • 生物活性

    • 实验参考方法

    • 纯度 & 产品资料

    • 参考文献

    生物活性

    6-Mercaptopurine hydrate (Mercaptopurine hydrate; 6-MP hydrate) is a purine analogue which acts as an antagonist of the endogenous purines and has been widely used as antileukemic agent and immunosuppressive agent.

    IC50 & Target

    endogenous purines[1]

    体外研究
    (In Vitro)

    6-Mercaptopurine hydrate (Mercaptopurine hydrate;6-MP hydrate) 以剂量响应方式诱导 NR4A3 转录活性 1.6 至 11 倍 (P<0.01)。结果发现,6-Mercaptopurine hydrate 导致 NR4A3 蛋白水平呈剂量依赖性增加。
    6-Mercaptopurine hydrate 处理使基底细胞和胰岛素中的细胞表面 GLUT4 增加 1.8 至 3.6 倍 (P<0.01) -刺激细胞比对照组高 2.9 至 4.4 倍 (P<0.01)。还发现 6-Mercaptopurine hydrate 在基础和胰岛素刺激条件下均以剂量响应方式显著增加磷酸化 AS160[2]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    体内研究
    (In Vivo)

    6-Mercaptopurine hydrate (6-MP) 处理组的胎儿端脑中,S 期细胞群在 36 和 48 小时增加,并在处理后 72 小时恢复到对照水平。G2/M期细胞数量在24小时开始增加,在36小时达到峰值,在48小时减少,最后在72小时回到对照水平。另一方面,亚G1期细胞群 (凋亡细胞) 在36小时开始增加,48小时达到峰值,然后在72小时减少[3]

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    分子量

    170.19

    Formula

    C5H6N4OS

    CAS 号
    性状

    固体

    颜色

    Light yellow to yellow

    中文名称

    6-巯基嘌呤水合物;6-巯基嘌呤 一水合物

    运输条件

    Room temperature in continental US; may vary elsewhere.

    储存方式
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    溶解性数据
    细胞实验: 

    DMSO 中的溶解度 : 50 mg/mL (293.79 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

    H2O 中的溶解度 : < 0.1 mg/mL (insoluble)

    配制储备液
    浓度 溶剂体积 质量 1 mg 5 mg 10 mg
    1 mM 5.8758 mL 29.3789 mL 58.7579 mL
    5 mM 1.1752 mL 5.8758 mL 11.7516 mL
    查看完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

    • 摩尔计算器

    • 稀释计算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    质量
    =
    浓度
    ×
    体积
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    浓度 (start)

    C1

    ×
    体积 (start)

    V1

    =
    浓度 (final)

    C2

    ×
    体积 (final)

    V2

    动物实验:

    请根据您的 实验动物和给药方式 选择适当的溶解方案。

    以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
    ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
    以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

    • 方案 一

      请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (14.69 mM); 澄清溶液

      此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。

      1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

      生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
    动物溶解方案计算器
    请输入动物实验的基本信息:

    给药剂量

    mg/kg

    动物的平均体重

    g

    每只动物的给药体积

    μL

    动物数量

    由于实验过程有损耗,建议您多配一只动物的量
    请输入您的动物体内配方组成:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
    方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
    计算结果
    工作液所需浓度 : mg/mL
    储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。
    您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
    动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
    连续给药周期超过半月以上,请谨慎选择该方案。
    请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
    纯度 & 产品资料

    纯度: 99.74%

    参考文献
    Kinase Assay
    [2]

    L6 myotubes are treated with DMSO control or 6-Mercaptopurine hydrate (6-MP) for 24 h, with the final 3 h of incubation including treatments in serum-free DMEM, and further incubated in the absence or presence of 100 nM insulin for 60 min at 37°C. Then, protein lysates (50 μg) are collected and subjected to SDS-PAGE. The proteins are finally quantified by densitometric analysis of scanned films using Image J software[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Assay
    [2]

    Cell viability is measured using Cell Viability Assay. L6 skeletal muscle cells are seeded in 96-well plates at a density of 10,000 cells/well and differentiated into myotubes within 7 days. Cells are treated with different doses of 6-Mercaptopurine hydrate (6-MP) for 24 h before the assay. For analysis of cell viability, plates are equilibrated at room temperature for 30 min; 50 μL of Cell Titer-Glo reagent is added to each well, and plates are mixed for 12 min on an orbital shaker. Luminescence is quantified using a luminometer[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3]

    Around thirteen-week-old pregnant rats are used in this study. The animals are housed individually in wire-mesh cages in an air-conditioned room (temperature, 23±3°C; humidity, 50±20%; ventilation, 10 times/hour; lighting, 12 h light to12 h dark cycle) and are given pelleted diet and water ad libitum. In the experiment, fifteen pregnant rats are injected i.p. with 50 mg/kg 6-Mercaptopurine hydrate (6-MP) on E13, and three dams each are sacrificed by exsanguination from the abdominal aorta under ether anesthesia at 12, 24, 36, 48, and 72 h. Fetuses are collected from each dam by Caesarean section. As controls, fifteen pregnant rats are injected i.p. with 2.0% methylcellulose solution in distilled water at E13, and three dams are sacrificed at each of the same time-points[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    参考文献

    完整储备液配制表

    * 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
    储备液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C储存时,请在2年内使用, -20°C储存时,请在1年内使用。

    可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 5.8758 mL 29.3789 mL 58.7579 mL 146.8946 mL
    5 mM 1.1752 mL 5.8758 mL 11.7516 mL 29.3789 mL
    10 mM 0.5876 mL 2.9379 mL 5.8758 mL 14.6895 mL
    15 mM 0.3917 mL 1.9586 mL 3.9172 mL 9.7930 mL
    20 mM 0.2938 mL 1.4689 mL 2.9379 mL 7.3447 mL
    25 mM 0.2350 mL 1.1752 mL 2.3503 mL 5.8758 mL
    30 mM 0.1959 mL 0.9793 mL 1.9586 mL 4.8965 mL
    40 mM 0.1469 mL 0.7345 mL 1.4689 mL 3.6724 mL
    50 mM 0.1175 mL 0.5876 mL 1.1752 mL 2.9379 mL
    60 mM 0.0979 mL 0.4896 mL 0.9793 mL 2.4482 mL
    80 mM 0.0734 mL 0.3672 mL 0.7345 mL 1.8362 mL
    100 mM 0.0588 mL 0.2938 mL 0.5876 mL 1.4689 mL
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的产品:

    Your information is safe with us. * Required Fields.

       产品名称:

     

    * 需求量:

    * 客户姓名:

     

    * Email:

    * 电话:

     

    * 公司或机构名称:

       留言给我们:

    Bulk Inquiry

    Inquiry Information

    产品名称:
    6-Mercaptopurine hydrate
    目录号:
    HY-13677A
    需求量: